Aurobindo Pharma’s buyback of ā¹800 crores approved by the board of directors at the meeting was held on April 6, 2026. Aurobindo Pharma Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ā¹1 each equity share at a price of ā¹1,475 per Equity Share and for an aggregate amount not exceeding ā¹800 crores from the shareholders. Check out Aurobindo Pharma Buyback 2026 details below:
Aurobindo Pharma Buyback About us
Aurobindo Pharma is one of the leading pharmaceutical companies that develops, manufactures, and sells a wide range of pharmaceutical ingredients. The companyās expertise lies in major therapeutic segments, including anti-infectives, cardiovascular, central nervous system (CNS), gastroenterology, and antiretrovirals.
Aurobindo Pharma, over time, expanded from selling generic medicines to advanced drugs, such as biosimilars, injectables, and speciality pharmaceuticals. Moreover, the firm runs its own in-house production process of its raw material, which benefits from maintaining high quality, avoiding supply disruptions, and cost efficiency. Furthermore, the firm supplies various types of medicines like Tablets, injections, and drugs to the top global countries like the United States and Europe
Aurobindo Pharma Buyback History
- N/A
Aurobindo Pharma Buyback 2026 Dates
| Buyback Meeting Date: | April 6, 2026 |
| Buyback Announcement Date: | April 6, 2026 |
| Buyback Record Date: | April 17, 2026 |
| Last Date to Buy Shares: | April 16, 2026 |
| Buyback Open Date: | April 23, 2026 |
| Buyback Close Date: | April 29, 2026 |
| Finalization of Buyback Acceptance: | 2026 |
Aurobindo Pharma Buyback 2026 Offer Details
Aurobindo Pharma Buyback of 54,23,728 equity shares at a price of ā¹1,475 per equity share. The buyback offers not to exceed ā¹800 crores of the total buyback offer size.
| Offer Amount: | ā¹800 Crores |
| Number of Shares: | 54,23,728 Equity Shares |
| Face Value: | ā¹1 per equity share |
| Buyback Price: | ā¹1,475 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
Aurobindo Pharma Buyback 2026 Acceptance Ratio
The investor should buy around 136 shares at a current market price of ā¹1342 (as of the date). The calculation will be ā¹2,00,000 / ā¹1,475 buyback price = 136 shares.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
| 33% | ā¹1,82,512 | 45 | ā¹5,985 |
| 50% | ā¹1,82,512 | 68 | ā¹9,044 |
| 75% | ā¹1,82,512 | 102 | ā¹13,566 |
| 100% | ā¹1,82,512 | 136 | ā¹18,088 |
Aurobindo Pharma Financial Report
| ā¹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ā¹13,226.04 | ā¹11,611.69 | ā¹1,230.41 |
| 2024 | ā¹11,261.70 | ā¹8,858.78 | ā¹1,954.14 |
| 2025 | ā¹11,261.42 | ā¹8,902.97 | ā¹1,746.79 |
How to Participate in Aurobindo Pharma Buyback 2026
The investors are eligible for the buyback scheme who have Aurobindo Pharma Buyback shares in their Demat Account as the Record Date. Eligible Share Holders can participate in the Aurobindo Pharma Buyback 2026 scheme as per the opening form by selling their shares. The payment will be given as per the Aurobindo Pharma Buyback accepted shares by the company under the Aurobindo Pharma Buyback scheme.
Aurobindo Pharma Buyback 2026 Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: aurobindo.buyback2026@kfintech.com
Website: https://ipostatus.kfintech.com/
Aurobindo Pharma Buyback 2026 Lead Managers
- Axial Capital Pvt.Ltd.
Aurobindo Pharma Company Address
Aurobindo Pharma Limited
Plot No. 2, Maithrivihar,
Ameerpet,
Hyderabad ā 500 038,
Telangana, India.
Phone: +91 40 6672 500
E-Mail: info@aurobindo.com
Website: https://www.aurobindo.com/
